A Message From Professor Rudy Nuijts Saturday May 9, 2020


Rudy Nuijts
Published: Monday, May 11, 2020
Dear Colleagues
We have some cause for optimism in today’s newsletter as governments across Europe and America loosen restrictions on the movements of their citizens and our colleagues make plans to open their practices for elective surgery and routine patient visits.
Of course, as we hear from Roberto Bellucci, Jesper Hjortdal and Jose Guell our practices are greatly transformed with social distancing, PPE and COVID-19 checks. It will take some time for these processes to become routine and many patients remain reluctant to attend the clinic. Hopefully antibody tests like the one described here will become widely available and make all of us more comfortable in all our activities.
Jose Guell explains how he has become an advocate for remote communications and telemedicine over the last two months. He believes it is the way for the future. Most certainly we will have a greater use of telemedicine for screening and perhaps diagnostics although as Roberto Belluci has highlighted, we do not have legal clarity on this activity.
We also report today on the remaining results of our COVID-19 questionnaire. The results in full will be published in the June issue of EuroTimes and on our website www.eurotimes.org.

Rudy Nuijts
Prof. dr Rudy MMA Nuijts
ESCRS President

Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.